United States Biotechnology & Medical Research

ARS Pharmaceuticals Inc (SPRY)

Track

ARS Pharmaceuticals Inc. has seen consistent insider selling activity, with executives including the Chief Legal Officer and Chief Commercial Officer executing planned sales in June 2026. These transactions follow a period where the stock price declined by 41.9% over the last 90 days, coinciding with a miss in the most recent earnings report.
Ticker: SPRY Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ARS Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
410.86
Quantity 18,345 -1.9%
Value US$4,948,125
3.3
Fitzpatrick Alexander A Chief Legal Officer Officer
Transaction date
Planned sale
Price
241.13
Quantity 47,633 -21.7%
Value US$588,260
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
155.07
Quantity 13,939
Value US$4,058,389
3.3
ALEXANDER FITZPATRICK Officer Officer
Transaction date
Proposed sale
Price
10.00
Quantity 3,355
Value US$33,550
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Sale
Price
8.71
Quantity 21,828 -66.9%
Value US$190,050
1.9
BRIAN T DORSEY Officer Officer
Transaction date
Proposed sale
Price
8.71
Quantity 21,828
Value US$190,050
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
8.86
Quantity 136,380 -100.0%
Value US$1,208,790
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
8.91
Quantity 30,000 -18.0%
Value US$267,357
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
9.00
Quantity 136,380
Value US$1,227,420
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
8.87
Quantity 138,380
Value US$1,227,420
3.2
JUSTIN CHAKMA Officer Officer
Transaction date
Proposed sale
Price
8.91
Quantity 30,000
Value US$267,357
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
14.49
Quantity 50,000 -4.0%
Value US$724,345
2.9
Scott Kathleen D. Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 12,500 -55.5%
Value US$187,500
2.9
KATHLEEN D SCOTT Officer Officer
Transaction date
Proposed sale
Price
15.00
Quantity 12,500
Value US$187,500
Lowenthal Richard E Officer; Director; Member of immediate family of any of the foregoing Executive Director
Transaction date
Proposed sale
Price
14.15
Quantity 150,000
Value US$2,123,000
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
14.09
Quantity 37,656 -2.9%
Value US$530,626
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
14.03
Quantity 12,344 -1.0%
Value US$173,130
Tanimoto Sarina Officer; Member of immediate family of any of the foregoing Officer
Transaction date
Proposed sale
Price
14.00
Quantity 150,000
Value US$2,100,000
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.99
Quantity 15,000 -59.3%
Value US$254,860
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
16.99
Quantity 15,000
Value US$254,859
2.8
Flynn James E Large shareholder
Transaction date
Sale
Price
18.46
Quantity 370,074 -7.0%
Value US$6,831,566
2.8
Flynn James E Large shareholder
Transaction date
Sale
Price
18.46
Quantity 370,075 -7.0%
Value US$6,831,584
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.00
Quantity 15,000 -66.1%
Value US$240,000
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
16.00
Quantity 15,000
Value US$240,000
3.1
SAUNDERS BRENT L Non-Executive Director
Transaction date
Sale
Price
14.25
Quantity 120,000 -100.0%
Value US$1,710,024
2.9
Scott Kathleen D. Chief Financial Officer Officer
Transaction date
Sale
Price
14.10
Quantity 50,000 -87.1%
Value US$705,165
3.3
Fitzpatrick Alexander A Chief Legal Officer Officer
Transaction date
Sale
Price
14.10
Quantity 102,969 -53.5%
Value US$1,451,513
2.9
Scott Kathleen D. Officer Officer
Transaction date
Proposed sale
Price
14.10
Quantity 50,000
Value US$705,000
3.3
Fitzpatrick Alexander A Officer Officer
Transaction date
Proposed sale
Price
14.02
Quantity 102,969
Value US$1,443,894
3.1
SAUNDERS BRENT L Director Non-Executive Director
Transaction date
Proposed sale
Price
14.25
Quantity 120,000
Value US$1,710,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
12.30
Quantity 50,002 -19.2%
Value US$615,075
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
12.30
Quantity 50,002
Value US$615,051
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
14.00
Quantity 10,000 -56.5%
Value US$140,000
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 10,000
Value US$140,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.21
Quantity 49,600 -19.1%
Value US$556,046
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.00
Quantity 400 -0.2%
Value US$4,400
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
11.00
Quantity 50,000
Value US$550,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
12.31
Quantity 50,000 -19.2%
Value US$615,565
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
12.31
Quantity 50,000
Value US$615,565
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.10
Quantity 50,000 -19.2%
Value US$555,065
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
11.10
Quantity 50,000
Value US$555,065
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -4.4%
Value US$583,525
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -3.7%
Value US$583,575
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -4.4%
Value US$583,525
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -3.7%
Value US$583,575
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
12.06
Quantity 27,272
Value US$328,967
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
12.06
Quantity 27,272 -16.7%
Value US$328,968
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Sale
Price
12.30
Quantity 25,000 -80.6%
Value US$307,432
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
12.27
Quantity 117,333 -46.2%
Value US$1,439,124
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Planned sale
Price
12.43
Quantity 15,000 -71.3%
Value US$186,426
1.9
Dorsey Brian Officer Officer
Transaction date
Proposed sale
Price
13.31
Quantity 61,200
Value US$814,572
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
11.50
Quantity 117,333
Value US$1,349,330
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
13.15
Quantity 50,000 -26.8%
Value US$657,625
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
13.16
Quantity 50,000 -4.2%
Value US$658,155
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
13.17
Quantity 50,000 -3.9%
Value US$658,265
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
13.16
Quantity 50,000 -4.2%
Value US$658,155
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
13.17
Quantity 50,000 -3.9%
Value US$658,265
3.2
Chakma Justin Director Non-Executive Director
Transaction date
Proposed sale
Price
14.02
Quantity 50,000
Value US$701,000
Lowenthal Richard E Officer; Director; Member of immediate family of any of the foregoing Executive Director
Transaction date
Proposed sale
Price
13.40
Quantity 300,000
Value US$4,020,000
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 50,000
Value US$700,000
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
14.23
Quantity 50,000 -26.8%
Value US$711,615
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
14.13
Quantity 49,640 -26.7%
Value US$701,642
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
13.32
Quantity 49,640
Value US$661,205
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
13.95
Quantity 45,000 -24.8%
Value US$627,944
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
14.51
Quantity 45,000
Value US$652,950
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 6,283
Value US$87,962
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
13.75
Quantity 14,772 -6.6%
Value US$203,109
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
14.00
Quantity 6,283 -52.5%
Value US$87,962
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
13.26
Quantity 87,984 -29.5%
Value US$1,166,897
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
13.19
Quantity 45,000 -24.8%
Value US$593,402
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
13.00
Quantity 45,000
Value US$585,000
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
13.57
Quantity 200,000
Value US$2,713,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
14.34
Quantity 901 -0.4%
Value US$12,922
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
13.55
Quantity 96,343 -31.3%
Value US$1,305,823
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
14.11
Quantity 3,717 -39.5%
Value US$52,461
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-12 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
18,345 -1.9%
410.86
US$4,948,125 		18,345 -1.9% 410.86 US$4,948,125
2026-06-12 2026-06-12 PlS Planned sale
3.3
Fitzpatrick Alexander A

Chief Legal Officer

Officer
47,633 -21.7%
241.13
US$588,260 		47,633 -21.7% 241.13 US$588,260
2026-06-12 2026-06-12 PrS Proposed sale
ERIC KARAS

Officer

Officer
13,939
155.07
US$4,058,389 		13,939 155.07 US$4,058,389
2026-06-12 2026-06-12 PrS Proposed sale
3.3
ALEXANDER FITZPATRICK

Officer

Officer
3,355
10.00
US$33,550 		3,355 10.00 US$33,550
2025-11-14 2025-11-13 S Sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
21,828 -66.9%
8.71
US$190,050 		21,828 -66.9% 8.71 US$190,050
2025-11-13 2025-11-13 PrS Proposed sale
1.9
BRIAN T DORSEY

Officer

Officer
21,828
8.71
US$190,050 		21,828 8.71 US$190,050
2025-11-14 2025-11-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
136,380 -100.0%
8.86
US$1,208,790 		136,380 -100.0% 8.86 US$1,208,790
2025-11-14 2025-11-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
30,000 -18.0%
8.91
US$267,357 		30,000 -18.0% 8.91 US$267,357
2025-11-12 2025-11-12 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
136,380
9.00
US$1,227,420 		136,380 9.00 US$1,227,420
2025-11-12 2025-11-12 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
138,380
8.87
US$1,227,420 		138,380 8.87 US$1,227,420
2025-11-12 2025-11-12 PrS Proposed sale
3.2
JUSTIN CHAKMA

Officer

Officer
30,000
8.91
US$267,357 		30,000 8.91 US$267,357
2025-08-22 2025-08-21 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.0%
14.49
US$724,345 		50,000 -4.0% 14.49 US$724,345
2025-08-22 2025-08-21 PlS Planned sale
2.9
Scott Kathleen D.

Chief Financial Officer

Officer
12,500 -55.5%
15.00
US$187,500 		12,500 -55.5% 15.00 US$187,500
2025-08-21 2025-08-21 PrS Proposed sale
2.9
KATHLEEN D SCOTT

Officer

Officer
12,500
15.00
US$187,500 		12,500 15.00 US$187,500
2025-08-21 2025-08-21 PrS Proposed sale
Lowenthal Richard E

Officer; Director; Member of immediate family of any of the foregoing

Executive Director
150,000
14.15
US$2,123,000 		150,000 14.15 US$2,123,000
2025-08-21 2025-08-20 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
37,656 -2.9%
14.09
US$530,626 		37,656 -2.9% 14.09 US$530,626
2025-08-21 2025-08-19 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
12,344 -1.0%
14.03
US$173,130 		12,344 -1.0% 14.03 US$173,130
2025-08-19 2025-08-19 PrS Proposed sale
Tanimoto Sarina

Officer; Member of immediate family of any of the foregoing

Officer
150,000
14.00
US$2,100,000 		150,000 14.00 US$2,100,000
2025-07-03 2025-07-01 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
15,000 -59.3%
16.99
US$254,860 		15,000 -59.3% 16.99 US$254,860
2025-07-01 2025-07-01 PrS Proposed sale
ERIC KARAS

Officer

Officer
15,000
16.99
US$254,859 		15,000 16.99 US$254,859
2025-07-01 2025-06-27 S Sale
2.8
Flynn James E
Large shareholder
370,074 -7.0%
18.46
US$6,831,566 		370,074 -7.0% 18.46 US$6,831,566
2025-07-01 2025-06-27 S Sale
2.8
Flynn James E
Large shareholder
370,075 -7.0%
18.46
US$6,831,584 		370,075 -7.0% 18.46 US$6,831,584
2025-06-20 2025-06-18 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
15,000 -66.1%
16.00
US$240,000 		15,000 -66.1% 16.00 US$240,000
2025-06-18 2025-06-18 PrS Proposed sale
ERIC KARAS

Officer

Officer
15,000
16.00
US$240,000 		15,000 16.00 US$240,000
2025-05-22 2025-05-20 S Sale
3.1
SAUNDERS BRENT L
Non-Executive Director
120,000 -100.0%
14.25
US$1,710,024 		120,000 -100.0% 14.25 US$1,710,024
2025-05-22 2025-05-20 S Sale
2.9
Scott Kathleen D.

Chief Financial Officer

Officer
50,000 -87.1%
14.10
US$705,165 		50,000 -87.1% 14.10 US$705,165
2025-05-22 2025-05-20 S Sale
3.3
Fitzpatrick Alexander A

Chief Legal Officer

Officer
102,969 -53.5%
14.10
US$1,451,513 		102,969 -53.5% 14.10 US$1,451,513
2025-05-20 2025-05-20 PrS Proposed sale
2.9
Scott Kathleen D.

Officer

Officer
50,000
14.10
US$705,000 		50,000 14.10 US$705,000
2025-05-20 2025-05-20 PrS Proposed sale
3.3
Fitzpatrick Alexander A

Officer

Officer
102,969
14.02
US$1,443,894 		102,969 14.02 US$1,443,894
2025-05-20 2025-05-20 PrS Proposed sale
3.1
SAUNDERS BRENT L

Director

Non-Executive Director
120,000
14.25
US$1,710,000 		120,000 14.25 US$1,710,000
2025-04-08 2025-04-07 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,002 -19.2%
12.30
US$615,075 		50,002 -19.2% 12.30 US$615,075
2025-04-07 2025-04-07 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,002
12.30
US$615,051 		50,002 12.30 US$615,051
2025-03-21 2025-03-20 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
10,000 -56.5%
14.00
US$140,000 		10,000 -56.5% 14.00 US$140,000
2025-03-20 2025-03-20 PrS Proposed sale
ERIC KARAS

Officer

Officer
10,000
14.00
US$140,000 		10,000 14.00 US$140,000
2025-03-07 2025-03-06 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
49,600 -19.1%
11.21
US$556,046 		49,600 -19.1% 11.21 US$556,046
2025-03-07 2025-03-05 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
400 -0.2%
11.00
US$4,400 		400 -0.2% 11.00 US$4,400
2025-03-05 2025-03-05 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
11.00
US$550,000 		50,000 11.00 US$550,000
2025-02-04 2025-02-03 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,000 -19.2%
12.31
US$615,565 		50,000 -19.2% 12.31 US$615,565
2025-02-03 2025-02-03 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
12.31
US$615,565 		50,000 12.31 US$615,565
2025-01-07 2025-01-06 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,000 -19.2%
11.10
US$555,065 		50,000 -19.2% 11.10 US$555,065
2025-01-06 2025-01-06 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
11.10
US$555,065 		50,000 11.10 US$555,065
2024-12-19 2024-12-17 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.4%
11.67
US$583,525 		50,000 -4.4% 11.67 US$583,525
2024-12-19 2024-12-17 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.7%
11.67
US$583,575 		50,000 -3.7% 11.67 US$583,575
2024-12-19 2024-12-17 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.4%
11.67
US$583,525 		50,000 -4.4% 11.67 US$583,525
2024-12-19 2024-12-17 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.7%
11.67
US$583,575 		50,000 -3.7% 11.67 US$583,575
2024-12-13 2024-12-13 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
27,272
12.06
US$328,967 		27,272 12.06 US$328,967
2024-12-13 2024-12-13 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
27,272 -16.7%
12.06
US$328,968 		27,272 -16.7% 12.06 US$328,968
2024-12-13 2024-12-12 S Sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
25,000 -80.6%
12.30
US$307,432 		25,000 -80.6% 12.30 US$307,432
2024-12-13 2024-12-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
117,333 -46.2%
12.27
US$1,439,124 		117,333 -46.2% 12.27 US$1,439,124
2024-12-13 2024-12-11 PlS Planned sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
15,000 -71.3%
12.43
US$186,426 		15,000 -71.3% 12.43 US$186,426
2024-12-11 2024-12-11 PrS Proposed sale
1.9
Dorsey Brian

Officer

Officer
61,200
13.31
US$814,572 		61,200 13.31 US$814,572
2024-12-12 2024-12-10 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
117,333
11.50
US$1,349,330 		117,333 11.50 US$1,349,330
2024-12-12 2024-12-10 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
50,000 -26.8%
13.15
US$657,625 		50,000 -26.8% 13.15 US$657,625
2024-12-11 2024-12-10 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.2%
13.16
US$658,155 		50,000 -4.2% 13.16 US$658,155
2024-12-11 2024-12-10 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.9%
13.17
US$658,265 		50,000 -3.9% 13.17 US$658,265
2024-12-11 2024-12-10 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.2%
13.16
US$658,155 		50,000 -4.2% 13.16 US$658,155
2024-12-11 2024-12-10 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.9%
13.17
US$658,265 		50,000 -3.9% 13.17 US$658,265
2024-12-10 2024-12-10 PrS Proposed sale
3.2
Chakma Justin

Director

Non-Executive Director
50,000
14.02
US$701,000 		50,000 14.02 US$701,000
2024-12-10 2024-12-10 PrS Proposed sale
Lowenthal Richard E

Officer; Director; Member of immediate family of any of the foregoing

Executive Director
300,000
13.40
US$4,020,000 		300,000 13.40 US$4,020,000
2024-12-06 2024-12-06 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
50,000
14.00
US$700,000 		50,000 14.00 US$700,000
2024-12-06 2024-12-06 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
50,000 -26.8%
14.23
US$711,615 		50,000 -26.8% 14.23 US$711,615
2024-12-06 2024-12-05 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
49,640 -26.7%
14.13
US$701,642 		49,640 -26.7% 14.13 US$701,642
2024-12-05 2024-12-05 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
49,640
13.32
US$661,205 		49,640 13.32 US$661,205
2024-12-06 2024-12-04 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
45,000 -24.8%
13.95
US$627,944 		45,000 -24.8% 13.95 US$627,944
2024-12-04 2024-12-04 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
45,000
14.51
US$652,950 		45,000 14.51 US$652,950
2024-12-04 2024-12-04 PrS Proposed sale
ERIC KARAS

Officer

Officer
6,283
14.00
US$87,962 		6,283 14.00 US$87,962
2024-12-04 2024-12-04 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
14,772 -6.6%
13.75
US$203,109 		14,772 -6.6% 13.75 US$203,109
2024-12-04 2024-12-04 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
6,283 -52.5%
14.00
US$87,962 		6,283 -52.5% 14.00 US$87,962
2024-12-04 2024-12-03 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
87,984 -29.5%
13.26
US$1,166,897 		87,984 -29.5% 13.26 US$1,166,897
2024-12-04 2024-12-03 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
45,000 -24.8%
13.19
US$593,402 		45,000 -24.8% 13.19 US$593,402
2024-12-03 2024-12-03 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
45,000
13.00
US$585,000 		45,000 13.00 US$585,000
2024-12-09 2024-12-02 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
200,000
13.57
US$2,713,000 		200,000 13.57 US$2,713,000
2024-12-04 2024-12-02 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
901 -0.4%
14.34
US$12,922 		901 -0.4% 14.34 US$12,922
2024-12-04 2024-12-02 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
96,343 -31.3%
13.55
US$1,305,823 		96,343 -31.3% 13.55 US$1,305,823
2024-12-04 2024-12-02 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
3,717 -39.5%
14.11
US$52,461 		3,717 -39.5% 14.11 US$52,461
Explore more

More insider trading research around ARS Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America